Loading…

Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model

Microbial secondary metabolites, which play a pivotal role in struggling with infectious diseases, are the new source for controlling bacterial contaminations and possess a strong antimicrobial potential. The present study is designed to evaluate the in vitro and in vivo bactericidal activities of p...

Full description

Saved in:
Bibliographic Details
Published in:ACS omega 2024-02, Vol.9 (7), p.8397-8404
Main Authors: Köksal Karayildirim, Çinel, Şahiner, Aslı, Çalişkan, Sennur, Soylu, Fahri Emrah, Gökhan, Aylin, Eroğlu, Ebru, Uyanikgil, Yiğit, Karayildirim, Tamer
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-a453t-fc7e2c3d13b9736debf78123ec9e3c2cafdd6fb4a2d561b045ca69f9fe1a951d3
container_end_page 8404
container_issue 7
container_start_page 8397
container_title ACS omega
container_volume 9
creator Köksal Karayildirim, Çinel
Şahiner, Aslı
Çalişkan, Sennur
Soylu, Fahri Emrah
Gökhan, Aylin
Eroğlu, Ebru
Uyanikgil, Yiğit
Karayildirim, Tamer
description Microbial secondary metabolites, which play a pivotal role in struggling with infectious diseases, are the new source for controlling bacterial contaminations and possess a strong antimicrobial potential. The present study is designed to evaluate the in vitro and in vivo bactericidal activities of prodigiosin against Staphylococcus aureus. For this purpose, Serratia marcescens was used to produce prodigiosin. Characterization of the prodigiosin was carried out using NMR. In addition, bioautographic detection of prodigiosin was detected by TLC. Antibacterial assays, in vivo epicutaneous infection tests, swap analyses, and histopathological examinations were determined. The results revealed that prodigiosin was detected by NMR and TLC. According to antimicrobial susceptibility tests, prodigiosin is an efficient bactericidal compound that demonstrated strong antibacterial activity toward S. aureus. In vivo, animal studies determined that the strong inhibition of S. aureus-caused epidermal infection occurs by prodigiosin at 48 h. Histopathological results showed that S. aureus + prodigiosin skin sections consist of improved and healthy tissues without any infection area compared with the S. aureus and control groups. The in vivo study verified the antibacterial results with swap analyses, and histopathological findings showed that prodigiosin is a promising microbial metabolite effective against S. aureus infection. This study proved that prodigiosin with excellent bioactivity exhibited antibacterial properties, which might possess massive potential for new therapeutic approaches using micro-organisms.
doi_str_mv 10.1021/acsomega.3c09522
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_348669a15a68416a91e63fe7789c9887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_348669a15a68416a91e63fe7789c9887</doaj_id><sourcerecordid>2932024624</sourcerecordid><originalsourceid>FETCH-LOGICAL-a453t-fc7e2c3d13b9736debf78123ec9e3c2cafdd6fb4a2d561b045ca69f9fe1a951d3</originalsourceid><addsrcrecordid>eNp1kk1v2zAMho1hw1p0ve806LhD0-nLsnQaiiJbA7TYYR9XgZaoTIFtZbIdoP9jP3hqkhbtYSeJ5MtHFMmqes_oJaOcfQI3ph7XcCkcNTXnr6pTLhu6YEKK18_uJ9X5OG4opUxprrl6W50ILWkthT6t_q7G1MEU03BBVh6HKYbojjYMnlwVTx9dTm2Ejix30M37KEmBfEeXBg_5ntzhBG3q4oQk5NSXSM5FBqSH7HB0OIxkV0wYyGogv-IukeU2unmCAdM8FmdAt8feJY_du-pNgG7E8-N5Vv38svxxfbO4_fZ1dX11uwBZi2kRXIPcCc9EaxqhPLah0YwLdAaF4w6C9yq0ErivFWuprB0oE0xABqZmXpxVqwPXJ9jYbY6l3HubINq9I-W1hTxF16EVUitlgNWgtGQKDEMlAjaNNs5o3RTW5wNrO7c9-vLlKUP3AvoyMsTfdp12llFdhqJZIXw8EnL6M-M42T6W1nXdoUmWG8Epl4rLIqUHaRnMOGYMT-8wah-Wwz4uhz0uR0n58Ly-p4THVSiCi4OgpNpNmvNQWv9_3j_VE8mm</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2932024624</pqid></control><display><type>article</type><title>Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model</title><source>American Chemical Society (ACS) Open Access</source><source>PubMed Central</source><creator>Köksal Karayildirim, Çinel ; Şahiner, Aslı ; Çalişkan, Sennur ; Soylu, Fahri Emrah ; Gökhan, Aylin ; Eroğlu, Ebru ; Uyanikgil, Yiğit ; Karayildirim, Tamer</creator><creatorcontrib>Köksal Karayildirim, Çinel ; Şahiner, Aslı ; Çalişkan, Sennur ; Soylu, Fahri Emrah ; Gökhan, Aylin ; Eroğlu, Ebru ; Uyanikgil, Yiğit ; Karayildirim, Tamer</creatorcontrib><description>Microbial secondary metabolites, which play a pivotal role in struggling with infectious diseases, are the new source for controlling bacterial contaminations and possess a strong antimicrobial potential. The present study is designed to evaluate the in vitro and in vivo bactericidal activities of prodigiosin against Staphylococcus aureus. For this purpose, Serratia marcescens was used to produce prodigiosin. Characterization of the prodigiosin was carried out using NMR. In addition, bioautographic detection of prodigiosin was detected by TLC. Antibacterial assays, in vivo epicutaneous infection tests, swap analyses, and histopathological examinations were determined. The results revealed that prodigiosin was detected by NMR and TLC. According to antimicrobial susceptibility tests, prodigiosin is an efficient bactericidal compound that demonstrated strong antibacterial activity toward S. aureus. In vivo, animal studies determined that the strong inhibition of S. aureus-caused epidermal infection occurs by prodigiosin at 48 h. Histopathological results showed that S. aureus + prodigiosin skin sections consist of improved and healthy tissues without any infection area compared with the S. aureus and control groups. The in vivo study verified the antibacterial results with swap analyses, and histopathological findings showed that prodigiosin is a promising microbial metabolite effective against S. aureus infection. This study proved that prodigiosin with excellent bioactivity exhibited antibacterial properties, which might possess massive potential for new therapeutic approaches using micro-organisms.</description><identifier>ISSN: 2470-1343</identifier><identifier>EISSN: 2470-1343</identifier><identifier>DOI: 10.1021/acsomega.3c09522</identifier><identifier>PMID: 38405438</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>ACS omega, 2024-02, Vol.9 (7), p.8397-8404</ispartof><rights>2024 The Authors. Published by American Chemical Society</rights><rights>2024 The Authors. Published by American Chemical Society.</rights><rights>2024 The Authors. Published by American Chemical Society 2024 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a453t-fc7e2c3d13b9736debf78123ec9e3c2cafdd6fb4a2d561b045ca69f9fe1a951d3</cites><orcidid>0000-0002-8431-1230</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsomega.3c09522$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsomega.3c09522$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27080,27924,27925,53791,53793,56762,56812</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38405438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Köksal Karayildirim, Çinel</creatorcontrib><creatorcontrib>Şahiner, Aslı</creatorcontrib><creatorcontrib>Çalişkan, Sennur</creatorcontrib><creatorcontrib>Soylu, Fahri Emrah</creatorcontrib><creatorcontrib>Gökhan, Aylin</creatorcontrib><creatorcontrib>Eroğlu, Ebru</creatorcontrib><creatorcontrib>Uyanikgil, Yiğit</creatorcontrib><creatorcontrib>Karayildirim, Tamer</creatorcontrib><title>Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model</title><title>ACS omega</title><addtitle>ACS Omega</addtitle><description>Microbial secondary metabolites, which play a pivotal role in struggling with infectious diseases, are the new source for controlling bacterial contaminations and possess a strong antimicrobial potential. The present study is designed to evaluate the in vitro and in vivo bactericidal activities of prodigiosin against Staphylococcus aureus. For this purpose, Serratia marcescens was used to produce prodigiosin. Characterization of the prodigiosin was carried out using NMR. In addition, bioautographic detection of prodigiosin was detected by TLC. Antibacterial assays, in vivo epicutaneous infection tests, swap analyses, and histopathological examinations were determined. The results revealed that prodigiosin was detected by NMR and TLC. According to antimicrobial susceptibility tests, prodigiosin is an efficient bactericidal compound that demonstrated strong antibacterial activity toward S. aureus. In vivo, animal studies determined that the strong inhibition of S. aureus-caused epidermal infection occurs by prodigiosin at 48 h. Histopathological results showed that S. aureus + prodigiosin skin sections consist of improved and healthy tissues without any infection area compared with the S. aureus and control groups. The in vivo study verified the antibacterial results with swap analyses, and histopathological findings showed that prodigiosin is a promising microbial metabolite effective against S. aureus infection. This study proved that prodigiosin with excellent bioactivity exhibited antibacterial properties, which might possess massive potential for new therapeutic approaches using micro-organisms.</description><issn>2470-1343</issn><issn>2470-1343</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>DOA</sourceid><recordid>eNp1kk1v2zAMho1hw1p0ve806LhD0-nLsnQaiiJbA7TYYR9XgZaoTIFtZbIdoP9jP3hqkhbtYSeJ5MtHFMmqes_oJaOcfQI3ph7XcCkcNTXnr6pTLhu6YEKK18_uJ9X5OG4opUxprrl6W50ILWkthT6t_q7G1MEU03BBVh6HKYbojjYMnlwVTx9dTm2Ejix30M37KEmBfEeXBg_5ntzhBG3q4oQk5NSXSM5FBqSH7HB0OIxkV0wYyGogv-IukeU2unmCAdM8FmdAt8feJY_du-pNgG7E8-N5Vv38svxxfbO4_fZ1dX11uwBZi2kRXIPcCc9EaxqhPLah0YwLdAaF4w6C9yq0ErivFWuprB0oE0xABqZmXpxVqwPXJ9jYbY6l3HubINq9I-W1hTxF16EVUitlgNWgtGQKDEMlAjaNNs5o3RTW5wNrO7c9-vLlKUP3AvoyMsTfdp12llFdhqJZIXw8EnL6M-M42T6W1nXdoUmWG8Epl4rLIqUHaRnMOGYMT-8wah-Wwz4uhz0uR0n58Ly-p4THVSiCi4OgpNpNmvNQWv9_3j_VE8mm</recordid><startdate>20240220</startdate><enddate>20240220</enddate><creator>Köksal Karayildirim, Çinel</creator><creator>Şahiner, Aslı</creator><creator>Çalişkan, Sennur</creator><creator>Soylu, Fahri Emrah</creator><creator>Gökhan, Aylin</creator><creator>Eroğlu, Ebru</creator><creator>Uyanikgil, Yiğit</creator><creator>Karayildirim, Tamer</creator><general>American Chemical Society</general><scope>N~.</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8431-1230</orcidid></search><sort><creationdate>20240220</creationdate><title>Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model</title><author>Köksal Karayildirim, Çinel ; Şahiner, Aslı ; Çalişkan, Sennur ; Soylu, Fahri Emrah ; Gökhan, Aylin ; Eroğlu, Ebru ; Uyanikgil, Yiğit ; Karayildirim, Tamer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a453t-fc7e2c3d13b9736debf78123ec9e3c2cafdd6fb4a2d561b045ca69f9fe1a951d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Köksal Karayildirim, Çinel</creatorcontrib><creatorcontrib>Şahiner, Aslı</creatorcontrib><creatorcontrib>Çalişkan, Sennur</creatorcontrib><creatorcontrib>Soylu, Fahri Emrah</creatorcontrib><creatorcontrib>Gökhan, Aylin</creatorcontrib><creatorcontrib>Eroğlu, Ebru</creatorcontrib><creatorcontrib>Uyanikgil, Yiğit</creatorcontrib><creatorcontrib>Karayildirim, Tamer</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>ACS omega</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Köksal Karayildirim, Çinel</au><au>Şahiner, Aslı</au><au>Çalişkan, Sennur</au><au>Soylu, Fahri Emrah</au><au>Gökhan, Aylin</au><au>Eroğlu, Ebru</au><au>Uyanikgil, Yiğit</au><au>Karayildirim, Tamer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model</atitle><jtitle>ACS omega</jtitle><addtitle>ACS Omega</addtitle><date>2024-02-20</date><risdate>2024</risdate><volume>9</volume><issue>7</issue><spage>8397</spage><epage>8404</epage><pages>8397-8404</pages><issn>2470-1343</issn><eissn>2470-1343</eissn><abstract>Microbial secondary metabolites, which play a pivotal role in struggling with infectious diseases, are the new source for controlling bacterial contaminations and possess a strong antimicrobial potential. The present study is designed to evaluate the in vitro and in vivo bactericidal activities of prodigiosin against Staphylococcus aureus. For this purpose, Serratia marcescens was used to produce prodigiosin. Characterization of the prodigiosin was carried out using NMR. In addition, bioautographic detection of prodigiosin was detected by TLC. Antibacterial assays, in vivo epicutaneous infection tests, swap analyses, and histopathological examinations were determined. The results revealed that prodigiosin was detected by NMR and TLC. According to antimicrobial susceptibility tests, prodigiosin is an efficient bactericidal compound that demonstrated strong antibacterial activity toward S. aureus. In vivo, animal studies determined that the strong inhibition of S. aureus-caused epidermal infection occurs by prodigiosin at 48 h. Histopathological results showed that S. aureus + prodigiosin skin sections consist of improved and healthy tissues without any infection area compared with the S. aureus and control groups. The in vivo study verified the antibacterial results with swap analyses, and histopathological findings showed that prodigiosin is a promising microbial metabolite effective against S. aureus infection. This study proved that prodigiosin with excellent bioactivity exhibited antibacterial properties, which might possess massive potential for new therapeutic approaches using micro-organisms.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>38405438</pmid><doi>10.1021/acsomega.3c09522</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-8431-1230</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2470-1343
ispartof ACS omega, 2024-02, Vol.9 (7), p.8397-8404
issn 2470-1343
2470-1343
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_348669a15a68416a91e63fe7789c9887
source American Chemical Society (ACS) Open Access; PubMed Central
title Isolation, Identification, and Antimicrobial Evaluation of Secondary Metabolite from Serratia marcescens via an In Vivo Epicutaneous Infection Model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T12%3A28%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isolation,%20Identification,%20and%20Antimicrobial%20Evaluation%20of%20Secondary%20Metabolite%20from%20Serratia%20marcescens%20via%20an%20In%20Vivo%20Epicutaneous%20Infection%20Model&rft.jtitle=ACS%20omega&rft.au=Ko%CC%88ksal%20Karayildirim,%20C%CC%A7inel&rft.date=2024-02-20&rft.volume=9&rft.issue=7&rft.spage=8397&rft.epage=8404&rft.pages=8397-8404&rft.issn=2470-1343&rft.eissn=2470-1343&rft_id=info:doi/10.1021/acsomega.3c09522&rft_dat=%3Cproquest_doaj_%3E2932024624%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a453t-fc7e2c3d13b9736debf78123ec9e3c2cafdd6fb4a2d561b045ca69f9fe1a951d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2932024624&rft_id=info:pmid/38405438&rfr_iscdi=true